SPY326.97-3.68 -1.11%
DIA271.44-5.08 -1.84%
IXIC10,778.80-14.48 -0.13%

Bloodworks Northwest To Test Donors For COVID-19 Antibodies Using Quotient's MosaiQ Test

Testing Conducted Using the Highly Accurate MosaiQ COVID-19 Antibody Test from Quotient JERSEY, Channel Islands, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Bloodworks Northwest is now offering all blood donors across the

 · 
  • Testing Conducted Using the Highly Accurate MosaiQ COVID-19 Antibody Test from Quotient

JERSEY, Channel Islands, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Bloodworks Northwest is now offering all blood donors across the Pacific Northwest free COVID-19 antibody testing with the possibility of discovering more qualified COVID-19 Convalescent Plasma (CCP) Donors. The testing is done with Quotient’s highly sensitive and specific COVID-19 antibody test utilizing Quotient’s high-throughput MosaiQ™ blood testing platform. The platform can process up to 3,000 samples a day, detecting antibodies with 100% sensitivity and 99.8% specificity.

“We’re encouraged by early results. Testing appears to be going well,” says Mark Destree, Executive Vice President for Bloodworks Laboratories. Destree plans on running the tests on all Bloodworks Northwest donor blood samples until September 30th, with the potential to extend longer. He adds, “We anticipate testing a total of 26,000 donors by the end of September, during a time when the demand for CCP may be increasing significantly.” Bloodworks Northwest’s Medical Director Dr. Rebecca Haley says, “So far, we’ve been able to send out more than 1,000 CCP units across the state of Washington and the United States, in response to the growing demand for this plasma.” Dr. Haley adds, “We anticipated the need for CCP would ramp up sometime this fall but the increase in demand is already here.”

Besides offering free COVID-19 antibody testing, Bloodworks Northwest is also looking for more CCP donors by building up its CCP donation program by expanding to Lynnwood, Everett and Vancouver, Washington (metropolitan Portland). In order to launch this program with the greatest degree of efficiency, Bloodworks has tested the procedure with cooperation from the U.S. Navy aboard the U.S.S. Roosevelt. The antibody test detects COVID-19 antibodies in the blood of donors who have recovered from a COVID-19 infection. This is important because those antibodies have shown promise in treating those infected by COVID-19.